Literature DB >> 1610080

Conjunctival vaccination of pregnant ewes and goats with Brucella melitensis Rev 1 vaccine: safety and serological responses.

E Zundel1, J M Verger, M Grayon, R Michel.   

Abstract

When Brucella melitensis strain Rev 1 vaccine (Rev 1) is administered by the standard method (1-2 x 10(9) viable bacteria injected subcutaneously), it may induce long-lasting serological responses and/or cause abortion in pregnant animals. The conjunctival route considerably reduces these drawbacks. In the present experiment a 1 x 10(8) CFU dose for both ewes and goats conjunctivally vaccinated at mid-pregnancy was tested for innocuousness (outcome of pregnancy, contamination of unvaccinated contact animals, duration of serological responses) in comparison with 3 x 10(8) CFU (ewes and goats), 1 x 10(9) and 3 x 10(9) CFU (ewes) doses. No reaction was observed at the time of vaccination, and the risk of environmental contamination with Rev 1, due to the conjunctival administration of the vaccine, is negligible. Abortions occurred later at surprisingly severe rates (over 60% of pregnant vaccinated animals), except in the 1 x 10(8) CFU ewes group (20%). Moreover, the serological reactions of the 1 x 10(8) CFU ewes which normally lambed were negative again as early as 12 weeks after vaccination. Although the dose of 1 x 10(8) CFU Rev 1 was safer for pregnancy than the standard dose mainly in ewes as compared to goats, the innocuousness was not yet sufficient to propose the former dose to indiscriminately vaccinate sheep and goats by the conjunctival route, whatever the age or physiological status.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610080

Source DB:  PubMed          Journal:  Ann Rech Vet        ISSN: 0003-4193


  12 in total

1.  Gaps in brucellosis eradication campaign in sheep and goats in Republic of Macedonia: lessons learned.

Authors:  Ivanco Naletoski; Toni Kirandziski; Dine Mitrov; Kiril Krstevski; Igor Dzadzovski; Sinisa Acevski
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

2.  Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats.

Authors:  E Díaz-Aparicio; C Marín; B Alonso-Urmeneta; V Aragón; S Pérez-Ortiz; M Pardo; J M Blasco; R Díaz; I Moriyón
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

3.  Human Brucellosis and Adverse Pregnancy Outcomes.

Authors:  Angela M Arenas-Gamboa; Carlos A Rossetti; Sankar P Chaki; Daniel G Garcia-Gonzalez; Leslie G Adams; Thomas A Ficht
Journal:  Curr Trop Med Rep       Date:  2016-10-01

4.  Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MΔvjbR strain in goats.

Authors:  M Raquel Castaño-Zubieta; Carlos A Rossetti; Daniel G García-González; Estefanía Maurizio; Martha E Hensel; Allison C Rice-Ficht; Thomas A Ficht; Ángela M Arenas-Gamboa
Journal:  Vaccine       Date:  2020-12-13       Impact factor: 3.641

5.  Innocuity and immune response to Brucella melitensis Rev.1 vaccine in camels (Camelus dromedarius).

Authors:  A Benkirane; A H El Idrissi; A Doumbia; K de Balogh
Journal:  Open Vet J       Date:  2014-10-25

6.  Brucella melitensis Rev.1 vaccination generates a higher shedding risk of the vaccine strain in Alpine ibex (Capra ibex) compared to the domestic goat (Capra hircus).

Authors:  Claire Ponsart; Mickaël Riou; Yann Locatelli; Isabelle Jacques; Alain Fadeau; Maryne Jay; Roland Simon; Ludivine Perrot; Luca Freddi; Sylvain Breton; Thierry Chaumeil; Barbara Blanc; Katia Ortiz; Colin Vion; Damien Rioult; Erwan Quéméré; Pierre Sarradin; Jean-Yves Chollet; Bruno Garin-Bastuji; Sophie Rossi
Journal:  Vet Res       Date:  2019-11-27       Impact factor: 3.683

7.  Protection from hemolytic uremic syndrome by eyedrop vaccination with modified enterohemorrhagic E. coli outer membrane vesicles.

Authors:  Kyoung Sub Choi; Sang-Hyun Kim; Eun-Do Kim; Sang-Ho Lee; Soo Jung Han; Sangchul Yoon; Kyu-Tae Chang; Kyoung Yul Seo
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

8.  Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets.

Authors:  Sangchul Yoon; Eun-Do Kim; Min-Suk Song; Soo Jung Han; Tae Kwann Park; Kyoung Sub Choi; Young-Ki Choi; Kyoung Yul Seo
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

9.  Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.

Authors:  Jennifer L Higgins; Mercedes Gonzalez-Juarrero; Richard A Bowen
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

10.  Ontology-Based Meta-Analysis of Animal and Human Adverse Events Associated With Licensed Brucellosis Vaccines.

Authors:  Jiangan Xie; Jessica Wang; Zhangyong Li; Wei Wang; Yu Pang; Yongqun He
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.